INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 119 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $931,000 | -61.6% | 700,000 | +126.5% | 0.00% | -60.0% |
| Q4 2015 | $2,426,000 | -13.6% | 309,095 | -7.0% | 0.01% | -16.7% |
| Q3 2015 | $2,807,000 | -29.5% | 332,200 | -8.7% | 0.01% | -20.0% |
| Q2 2015 | $3,983,000 | +188.4% | 363,751 | +268.4% | 0.02% | +200.0% |
| Q1 2015 | $1,381,000 | -45.0% | 98,751 | -33.6% | 0.01% | -44.4% |
| Q4 2014 | $2,512,000 | -38.7% | 148,751 | -51.3% | 0.01% | -40.0% |
| Q3 2014 | $4,099,000 | +4.0% | 305,451 | -1.3% | 0.02% | +15.4% |
| Q2 2014 | $3,942,000 | +22.5% | 309,451 | +14.3% | 0.01% | +8.3% |
| Q1 2014 | $3,219,000 | -1.0% | 270,750 | +15.0% | 0.01% | 0.0% |
| Q4 2013 | $3,250,000 | -34.9% | 235,350 | -17.7% | 0.01% | -36.8% |
| Q3 2013 | $4,991,000 | +15.5% | 286,000 | +7.5% | 0.02% | +11.8% |
| Q2 2013 | $4,323,000 | – | 266,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |